Thursday, October 16, 2014

MID Labs Sees $51M

San Leandro-based MID Labs said today that it has raised $51M in funding for its medical devices. The company, which develops products for vitreoretinal surgery, said the funding was led by OrbiMed and Frontline BioVentures, and also included Softbank China Venture Capital (SBCVC), Allen Chao and Sungent BioVenture. MID Labs is led by Dr. Kai Chen. The company's products are used in opthalmic surgery.